Drug:
Reaction: DYSPNOEA
20250101 - 20251231
No. 501 - 600
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
501 | 25120695 |
CA |
44 | 2 |
Malaise, Lung disorder, Ill-defined disorder, Adjustment disorder with depressed mood, Alopecia, Amnesia, Breast cancer stage III, Colitis ulcerative, Deep vein thrombosis, Delirium, Dislocation of vertebra, Depression, Dizziness, Dyspnoea, Feeling hot, Medication error, Obesity, Paraesthesia, Peripheral venous disease, Porphyria acute, Prescribed overdose, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Systemic lupus erythematosus, Treatment failure, Type 2 diabetes mellitus, Upper respiratory tract infection, Weight fluctuation, Wound infection, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, OXYCODONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PREGABALIN, SECUKINUMAB, SECUKINUMAB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, NEOMYCIN OINTMENT, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
502 | 25120728 |
US |
67 | 2 |
Dyspnoea, Headache, Rash, |
||||
TADALAFIL, SELEXIPAG, SOTATERCEPT-CSRK, FAMOTIDINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CETIRIZINE HYDROCHLORIDE, CARVEDILOL, AMLODIPINE BESYLATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ALLOPURINOL, ERGOCALCIFEROL, LOSARTAN, PSYLLIUM HUSK, |
||||
503 | 25120811 |
US |
66 | 2 |
Dyspnoea, Diaphragmatic paralysis, Post-acute COVID-19 syndrome, Influenza like illness, Asthenia, Mobility decreased, Pneumonia, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
504 | 25123631 |
74 | 2 | |
Oropharyngeal pain, Lymphadenopathy, Swollen tongue, Pharyngeal swelling, Dysphagia, Dyspnoea, |
||||
MINERAL OIL, PETROLATUM, |
||||
505 | 25124628 |
71 | 1 | |
Dyspnoea, Hyperhidrosis, Diplegia, Monoplegia, Facial paralysis, Haemorrhage, |
||||
EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
506 | 25124906 |
|||
Dyspnoea, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
507 | 25124911 |
66 | 2 | |
Dyspnoea, Blood potassium decreased, |
||||
CAPECITABINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
508 | 25109848 |
GB |
1 | |
Dyspnoea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
509 | 25109936 |
US |
||
Eye disorder, Drug ineffective, Product packaging quantity issue, Product use issue, Off label use, Product dose omission issue, Wrong technique in device usage process, Dyspnoea, Fatigue, Urinary tract infection, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
510 | 25110112 |
CA |
40 | 2 |
Drug-induced liver injury, Drug hypersensitivity, Folliculitis, Gastrooesophageal reflux disease, Fatigue, Dyspnoea, Dyspepsia, Gait inability, Finger deformity, Drug intolerance, Gastrointestinal disorder, General physical health deterioration, |
||||
TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ATOMOXETINE, ERENUMAB-AOOE, ERENUMAB-AOOE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, NAPROXEN, MEPOLIZUMAB, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LAMOTRIGINE, LAMOTRIGINE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, RAMIPRIL, RAMIPRIL, RAMIPRIL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, APREMILAST, CANDESARTAN, BUPRENORPHINE, THIAMINE HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREMILAST, APREMILAST, APREMILAST, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, INFLIXIMAB, INFLIXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MINOCYCLINE HYDROCHLORIDE, ERGOCALCIFEROL, NICOTINAMIDE, BOTULINUM TOXIN TYPE A, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE, VITAMIN A, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROCORTISONE BUTYRATE, GOLD, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MIRABEGRON, MIRABEGRON, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MINOCYCLINE, MINOCYCLINE, GOLIMUMAB, PHENYLEPHRINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, RANITIDINE, RANITIDINE HYDROCHLORIDE, |
||||
511 | 25110156 |
US |
88 | 1 |
Dyspnoea, Therapy non-responder, |
||||
MACITENTAN, TREPROSTINIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FUROSEMIDE, APIXABAN, ALBUTEROL SULFATE, ROPINIROLE HYDROCHLORIDE, OXYGEN, 0XYGEN, LISINOPRIL, ERYTHROMYCIN, SILDENAFIL CITRATE, SILDENAFIL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, IRON, BICALUTAMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
512 | 25110224 |
CA |
69 | 2 |
Dyspnoea, Blood pressure increased, Nausea, Alopecia, Dysphonia, Hypotension, Asthenia, Oropharyngeal pain, Fatigue, Diarrhoea, Headache, |
||||
NINTEDANIB, NINTEDANIB, |
||||
513 | 25110280 |
DE |
63 | 1 |
Pneumonitis, Acute respiratory distress syndrome, Dyspnoea, |
||||
NIVOLUMAB, NIVOLUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
514 | 25110288 |
US |
67 | 2 |
Device malfunction, Dyspnoea, Off label use, |
||||
515 | 25110357 |
US |
70 | 1 |
Dyspnoea, Dyspnoea exertional, Flushing, Productive cough, Somnolence, Weight decreased, Headache, Abdominal discomfort, Dizziness, Nausea, Fatigue, Abdominal pain upper, |
||||
SEMAGLUTIDE, OXYGEN, 0XYGEN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
516 | 25110527 |
GB |
88 | 2 |
Hepatotoxicity, Hepatic cirrhosis, Acute kidney injury, Hepatitis, Decreased appetite, Dyspnoea, Abdominal distension, Carbohydrate antigen 125 increased, Condition aggravated, Dyspepsia, Nausea, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, WATER, ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BECLOMETHASONE DIPROPIONATE, TEMAZEPAM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, LOSARTAN, ISOSORBIDE MONONITRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NITROGLYCERIN, METHYLPREDNISOLONE ACETATE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CHLORPHENIRAMINE MALEATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE, FUROSEMIDE, |
||||
517 | 25110571 |
US |
||
Dyspnoea, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, ALBUTEROL SULFATE, ERGOCALCIFEROL, FISH OIL, OIL, BIOTIN, HAIR, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, |
||||
518 | 25110723 |
US |
||
Dyspnoea, Injection site pain, Drug dose omission by device, Device delivery system issue, Wrong technique in device usage process, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
519 | 25110758 |
CN |
||
Cough, Dyspnoea, Pneumonitis, Thyroiditis, Decreased appetite, Fatigue, Neutropenia, Rash, Skin reaction, Pyrexia, Alopecia, Pruritus, Insomnia, Nausea, Vomiting, Constipation, Diarrhoea, Anaemia, Thrombocytopenia, |
||||
ATEZOLIZUMAB, |
||||
520 | 25110790 |
DE |
90 | 1 |
Chest pain, Bundle branch block right, Dyspnoea, Hypotension, |
||||
BENDAMUSTINE HCL, ALLOPURINOL, BISOPROLOL FUMARATE, ACYCLOVIR, APIXABAN, ENZALUTAMIDE, |
||||
521 | 25110813 |
US |
60 | |
Dyspnoea, Respiratory disorder, Asthma, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
522 | 25110929 |
GB |
75 | 2 |
Death, Cardiac arrest, Malaise, Dyspnoea, |
||||
IOHEXOL, |
||||
523 | 25111001 |
FR |
69 | |
Dyspnoea, Haematoma, Pruritus, Cholecystitis, Chest discomfort, |
||||
TICAGRELOR, |
||||
524 | 25111008 |
US |
||
Dyspnoea, |
||||
BENRALIZUMAB, |
||||
525 | 25111019 |
US |
23 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device deposit issue, |
||||
ALBUTEROL SULFATE, |
||||
526 | 25111058 |
GB |
83 | 2 |
Back pain, Nausea, Abdominal pain upper, Blood glucose increased, Amnesia, Blindness, Immunisation, Alopecia, Pyrexia, Tension headache, Migraine, Intentional product misuse, Intentional product use issue, Intentional product misuse, Off label use, Off label use, Product use issue, Medication error, Incorrect product administration duration, Product use in unapproved indication, Subarachnoid haemorrhage, Diarrhoea, Malaise, Abdominal discomfort, Headache, Nausea, Hallucination, Angioedema, Malaise, COVID-19, Dizziness, Tinnitus, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Blindness, Diplopia, Blindness, Vasculitis, Carotid artery occlusion, Transient ischaemic attack, Pruritus genital, Sleep terror, Fatigue, Vomiting, Ventricular tachycardia, Pericarditis, Cardiospasm, Dyspnoea, Atrial tachycardia, Fatigue, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Heart rate increased, Muscle twitching, Abdominal pain upper, Dehydration, Hyperhidrosis, Rash papular, Lip swelling, Pruritus, Palmoplantar keratoderma, Dry skin, Myocardial infarction, Chest pain, Palpitations, Tachycardia, Pain, Anosmia, Eye pruritus, Facial pain, Fatigue, Abdominal discomfort, |
||||
NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, DAPAGLIFLOZIN, DAPAGLIFLOZIN, ISOSORBIDE MONONITRATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, AMITRIPTYLINE HYDROCHLORIDE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, |
||||
527 | 25111233 |
CA |
20 | 2 |
Akathisia, Tetany, Dyspnoea, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, CEFTRIAXONE, CEFTRIAXONE SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ERTAPENEM, ERTAPENEM SODIUM, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, NAPROXEN, NAPROXEN SODIUM, |
||||
528 | 25111234 |
US |
2 | |
Respiratory tract congestion, Dyspnoea, Cough, Product dose omission issue, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, OXYGEN, 0XYGEN, |
||||
529 | 25111313 |
TW |
48 | |
Nausea, Vomiting, Abdominal pain, Dyspnoea, Blood glucose increased, Urine ketone body present, Blood lactic acid increased, |
||||
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, TICAGRELOR, |
||||
530 | 25111424 |
CA |
||
Asthma, Chest pain, Cough, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, Drug hypersensitivity, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, CALCIUM, CALCIUM, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, CLONAZEPAM, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, THEOPHYLLINE, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, |
||||
531 | 25111457 |
CA |
56 | 1 |
Adenoidectomy, Asthma, Atelectasis, Blood immunoglobulin E increased, Bronchial secretion retention, Bronchial wall thickening, Bronchiolitis, Chronic obstructive pulmonary disease, Diaphragmatic disorder, Emphysema, Eosinophil count increased, Full blood count abnormal, Gastrooesophageal reflux disease, Hospitalisation, Idiopathic interstitial pneumonia, Increased appetite, Loss of personal independence in daily activities, Lung diffusion disorder, Mediastinal mass, Migraine, Mycobacterial infection, Nasal congestion, Nasal oedema, Nasal polyps, Obstructive airways disorder, Productive cough, Pulmonary eosinophilia, Pulmonary granuloma, Pulmonary mass, Respiratory disorder, Sleep disorder due to a general medical condition, Sputum discoloured, Therapeutic product effect incomplete, Tonsillectomy, Umbilical hernia, Vasculitis, Weight increased, Wheezing, Abdominal distension, Dyspnoea, Dyspnoea exertional, Asthenia, Chest discomfort, Dry mouth, Headache, Palpitations, |
||||
BUDESONIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PREDNISONE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
532 | 25111498 |
GB |
2 | |
Respiratory failure, Dyspnoea, Influenza, Malignant neoplasm progression, Breast cancer metastatic, Anaemia, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
533 | 25111504 |
SE |
6 | 2 |
Dyspnoea, Drug dose omission by device, Device malfunction, |
||||
BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, |
||||
534 | 25111534 |
CA |
2 | |
Type 2 diabetes mellitus, Gait disturbance, Alopecia, Malaise, Back disorder, Fluid retention, Liver injury, Injury, Hypertension, Nausea, Sleep disorder, Memory impairment, Vomiting, Wound, Glossodynia, Hypoaesthesia, Blood cholesterol increased, Hepatic enzyme increased, Helicobacter infection, Oedema, Rash vesicular, Swelling, Abdominal discomfort, Diarrhoea, Pulmonary fibrosis, Anti-cyclic citrullinated peptide antibody positive, Stomatitis, Infusion related reaction, Pain, Breast cancer stage II, Decreased appetite, Peripheral swelling, X-ray abnormal, Pain in extremity, Grip strength decreased, Joint range of motion decreased, Dyspnoea, Pneumonia, General physical health deterioration, Dyspepsia, Psoriatic arthropathy, Mobility decreased, Pericarditis, Arthropathy, Gait inability, Joint swelling, Dislocation of vertebra, Drug hypersensitivity, Hypercholesterolaemia, Impaired healing, Condition aggravated, Psoriasis, Fatigue, Swollen joint count increased, Weight increased, Synovitis, Fibromyalgia, Folliculitis, Nasopharyngitis, Pruritus, Systemic lupus erythematosus, Infection, Abdominal pain upper, Contusion, Confusional state, Duodenal ulcer perforation, Muscle injury, Urticaria, Ill-defined disorder, Wound infection, Wheezing, Headache, Gastrointestinal disorder, Blister, Rash, Lower respiratory tract infection, Hypersensitivity, Subcutaneous drug absorption impaired, Irritable bowel syndrome, Myositis, Weight decreased, Chest pain, Sinusitis, Delirium, Discomfort, Depression, Arthralgia, Rheumatic fever, General symptom, Pemphigus, Amnesia, Migraine, Adjustment disorder with depressed mood, Sleep disorder due to general medical condition, insomnia type, Hand deformity, Musculoskeletal stiffness, Pustular psoriasis, Rheumatoid arthritis, Pyrexia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CALCIUM CARBONATE, VITAMIN C, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, NAPROXEN, NAPROXEN SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SECUKINUMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, LISINOPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RAMIPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LANSOPRAZOLE, DESOGESTREL AND ETHINYL ESTRADIOL, CAFFEINE CITRATE, CALCIUM GLUCONATE, LORAZEPAM, ALENDRONATE SODIUM, |
||||
535 | 25111590 |
GB |
85 | 1 |
Medication error, Dyspnoea, Dizziness, Tremor, Restless legs syndrome, Gait disturbance, |
||||
LATANOPROST, |
||||
536 | 25111596 |
LV |
60 | 1 |
Acute kidney injury, Renal tubular necrosis, Glomerulonephritis minimal lesion, Nephrotic syndrome, Dyspnoea, Oedema peripheral, Proteinuria, |
||||
DICLOFENAC, DICLOFENAC SODIUM, |
||||
537 | 25111603 |
US |
2 | |
Dyspnoea, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
538 | 25111625 |
SG |
54 | 1 |
Dyspnoea, Flushing, |
||||
CELECOXIB, |
||||
539 | 25111650 |
CN |
58 | 1 |
Pyrexia, Hypotension, Chest discomfort, Dyspnoea, Off label use, |
||||
RITUXIMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
540 | 25111660 |
PL |
36 | 2 |
Restlessness, Dyspnoea, Erythema, |
||||
MANNITOL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
541 | 25111725 |
GB |
66 | 1 |
Dyspnoea, |
||||
ROSUVASTATIN CALCIUM, AMOXICILLIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
542 | 25111833 |
US |
56 | 2 |
Pneumonia, Asthma, Eye infection, Condition aggravated, Swelling of eyelid, Eyelid pain, Abnormal sensation in eye, Dry eye, Chest pain, Dyspnoea, Inflammation, |
||||
TOFACITINIB, |
||||
543 | 25111844 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, Oedema, Pain, |
||||
AMLODIPINE, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, THEOPHYLLINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ERGOCALCIFEROL, OMALIZUMAB, RITUXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MONTELUKAST SODIUM, |
||||
544 | 25112072 |
IT |
44 | 2 |
Dyspnoea, Catatonia, Back pain, |
||||
PACLITAXEL, PEMBROLIZUMAB, CARBOPLATIN, |
||||
545 | 25112163 |
US |
||
Cardiac failure, Pulmonary arterial hypertension, Impaired gastric emptying, Catheterisation cardiac, Taste disorder, Dyspnoea, Drug effect less than expected, Fall, Tendon injury, Wound complication, Concussion, Dizziness, Ear discomfort, Headache, Swelling, Dyspnoea, Asthma, Brain fog, Abdominal pain upper, Depression, Fear of falling, Cough, Urinary incontinence, Anal incontinence, |
||||
BENRALIZUMAB, |
||||
546 | 25112185 |
EG |
2 | |
Pulmonary fibrosis, Dizziness, Red blood cell sedimentation rate increased, Alopecia, C-reactive protein increased, Nasopharyngitis, Mobility decreased, Rheumatoid arthritis, Dyspnoea, Tachycardia, Blood glucose decreased, Vomiting, Diarrhoea, Hypotension, |
||||
UPADACITINIB, HYDROCORTISONE, RIVAROXABAN, ESOMEPRAZOLE MAGNESIUM, MESALAMINE, |
||||
547 | 25112202 |
AU |
30 | 1 |
Myocarditis, Oropharyngeal pain, Dyspnoea, Myalgia, Pyrexia, Chest pain, |
||||
CLOZAPINE, |
||||
548 | 25112221 |
GB |
1 | |
Cardiac arrest, Pain, Pyrexia, Condition aggravated, Dyspnoea, Swelling, Coma, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
549 | 25112318 |
US |
63 | 1 |
Dyspnoea, Cough, Wheezing, Product complaint, |
||||
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
550 | 25112374 |
US |
||
Dyspnoea, Illness, Drug dose omission by device, Device delivery system issue, Device deposit issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
551 | 25112666 |
CA |
73 | 2 |
Arthritis, Asthma, Depression, Dyspnoea, Glaucoma, Sleep apnoea syndrome, |
||||
CICLESONIDE, CICLESONIDE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, GABAPENTIN, GABAPENTIN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, TELMISARTAN, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE BESYLATE, GABAPENTIN, PREDNISONE, TELMISARTAN, GLYCOPYRROLATE, CYANOCOBALAMIN, CYANOCOBALAMIN, GLYCOPYRROLATE, |
||||
552 | 25112668 |
US |
||
Pharyngeal haemorrhage, Pain, Skin fissures, Wound complication, Renal pain, Dyspnoea, Dry mouth, Plicated tongue, Tongue haemorrhage, Pain in extremity, Back pain, Faeces hard, Headache, Eye pain, Glossodynia, Tongue dry, Dry throat, Accidental exposure to product, Product formulation issue, |
||||
MUPIROCIN, MUPIROCIN CALCIUM, |
||||
553 | 25112794 |
CA |
53 | 1 |
Dyspnoea, Cough, Hyperhidrosis, Pyrexia, Chills, Viral infection, Wheezing, Asthma, Respiratory tract infection, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
554 | 25112873 |
US |
2 | |
Flushing, Ocular hyperaemia, Chest discomfort, Dyspnoea, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
555 | 25112914 |
US |
46 | 1 |
Depression, Chest discomfort, Dyspnoea, Headache, Palpitations, Anxiety, |
||||
BIMEKIZUMAB, |
||||
556 | 25112972 |
DE |
10 | 2 |
Flushing, Dyspnoea, Oxygen saturation decreased, Anaphylactic reaction, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
557 | 25113350 |
HR |
71 | 1 |
Rash, Dyspnoea, |
||||
RASAGILINE MESYLATE, PERINDOPRIL ERBUMINE, PRAMIPEXOLE, |
||||
558 | 25113362 |
US |
2 | |
Arthralgia, Myalgia, Pruritus, Mood altered, Fatigue, Dyspnoea, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LISINOPRIL, BUPROPION HYDROCHLORIDE, AMLODIPINE BESYLATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, EZETIMIBE, |
||||
559 | 25113385 |
PT |
63 | 1 |
Throat tightness, Angioedema, Erythema, Dyspnoea, Pruritus, |
||||
DICLOFENAC, DICLOFENAC SODIUM, |
||||
560 | 25113390 |
PT |
||
Haemorrhagic stroke, Sepsis, Cardio-respiratory arrest, Altered state of consciousness, Headache, Diplopia, Pruritus, Sepsis, Haemorrhagic stroke, Fall, Diarrhoea, Blindness, Tachycardia, Fatigue, Pruritus, Asthenia, Urinary tract disorder, Haematemesis, Arthralgia, Myalgia, Syncope, Malaise, Photophobia, Cough, Vision blurred, Decreased appetite, Vomiting, Coma, Somnolence, Dizziness, Pyrexia, Somnolence, Blood pressure increased, Ocular discomfort, Head discomfort, Chills, Presyncope, Insomnia, Generalised oedema, Tinnitus, Amaurosis fugax, Dyspnoea, Ascites, Haematuria, Abdominal pain upper, Abdominal pain, Nausea, Drug interaction, Diplopia, Eye pain, Off label use, |
||||
MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, EZETIMIBE, EZETIMIBE, EZETIMIBE, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, |
||||
561 | 25113404 |
US |
2 | |
Gait disturbance, Fatigue, Neck pain, Dyspnoea, |
||||
OCRELIZUMAB, |
||||
562 | 25113431 |
FR |
71 | |
Chest pain, Myocarditis, Dyspnoea, Condition aggravated, |
||||
DURVALUMAB, |
||||
563 | 25113479 |
CA |
36 | 2 |
Diabetes mellitus, Asthma, Malaise, Metabolic disorder, Sneezing, Urticaria, Body mass index increased, Cough, Drug ineffective, Dyspnoea, Food allergy, Glucose tolerance impaired, Injection site bruising, Diarrhoea, Insomnia, Weight increased, Lung disorder, Wheezing, Fatigue, Nausea, Lethargy, Weight decreased, COVID-19, Skin sensitisation, Inappropriate schedule of product administration, Vomiting, Middle insomnia, Blood pressure increased, Sinus disorder, Product dose omission issue, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, ESCITALOPRAM OXALATE, ESCITALOPRAM, MEDROXYPROGESTERONE ACETATE, |
||||
564 | 25113508 |
NL |
64 | 2 |
Electrocardiogram QT prolonged, Aphasia, Dyspnoea, Dry eye, Dry mouth, Visual impairment, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, LORAZEPAM, LORAZEPAM, |
||||
565 | 25113522 |
US |
2 | |
Atrial fibrillation, Dyspnoea, Neuralgia, Condition aggravated, Abdominal discomfort, |
||||
MIGALASTAT HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ALLOPURINOL, APIXABAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, DOFETILIDE, BUPROPION HYDROCHLORIDE, LISINOPRIL, FUROSEMIDE, |
||||
566 | 25113581 |
CN |
||
Condition aggravated, Drug ineffective, Dyspnoea, |
||||
567 | 25113589 |
US |
63 | 1 |
Myocardial infarction, Asthma, Dyspnoea, Fatigue, Sneezing, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
568 | 25113609 |
CH |
53 | 1 |
Dyspnoea, Fear of death, Mood altered, Rash maculo-papular, Nausea, |
||||
ZOLPIDEM TARTRATE, |
||||
569 | 25113853 |
CA |
60 | |
Asthma, Blood lactic acid increased, Blood potassium decreased, Breath sounds abnormal, Chest X-ray abnormal, Chest discomfort, Cough, Dyspnoea, Ear pruritus, Eosinophilia, Eye pruritus, Full blood count abnormal, Lacrimation increased, Lung disorder, Nasal congestion, Nasal polyps, Platelet count increased, Pulmonary function test abnormal, Rhinitis allergic, Rhinorrhoea, Sneezing, Upper-airway cough syndrome, Urticaria, Vasculitis, Wheezing, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, CEFTRIAXONE, CEFTRIAXONE SODIUM, MEPOLIZUMAB, OMALIZUMAB, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, OSELTAMIVIR PHOSPHATE, |
||||
570 | 25113856 |
US |
62 | 2 |
Asthenia, Bacteraemia, Dyspnoea, Anaemia, Urinary tract infection, Dysstasia, Arrhythmia, |
||||
TRIFLURIDINE AND TIPIRACIL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE MALEATE, ANORECTAL OINTMENT, POLYETHYLENE GLYCOL 3350, |
||||
571 | 25113857 |
GB |
57 | 2 |
Cardiac failure, Dyspnoea, Back pain, |
||||
ALIROCUMAB, |
||||
572 | 25113940 |
US |
||
Dyspnoea, Vision blurred, Breath holding, Arthritis, Musculoskeletal discomfort, Product use issue, Device delivery system issue, Product dispensing issue, Product lot number issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
573 | 25113969 |
US |
2 | |
Terminal state, Overweight, Haemorrhage, Injection site extravasation, Device malfunction, Inappropriate schedule of product administration, Product dose omission issue, Off label use, Speech disorder, Malaise, Dyspnoea, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
574 | 25114037 |
US |
75 | 2 |
Urticaria, Dyspnoea, Pruritus, Throat tightness, Drug hypersensitivity, Incorrect dose administered, Product lot number issue, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
575 | 25114168 |
GB |
79 | |
Swollen tongue, Swelling face, Pharyngeal swelling, Dyspnoea, Palpitations, |
||||
DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
576 | 25114170 |
PL |
83 | 2 |
Eye pruritus, Dizziness, Hyponatraemia, Hallucination, Cognitive disorder, Multiple drug therapy, Vertigo, Pruritus, Dementia, Hypoglycaemia, Urinary retention, Fall, Osteoporosis, Parkinsonism, Hiatus hernia, Drug dependence, Hyperkalaemia, Gastric polyps, Constipation, Dysuria, Atrioventricular block first degree, Blood pressure decreased, Mobility decreased, Depression, Arthralgia, Initial insomnia, Melaena, Blood urea increased, Labelled drug-drug interaction issue, Blood cholesterol decreased, Insomnia, Blood creatine increased, Abdominal pain upper, Hypotension, Syncope, Peripheral circulatory failure, Drug interaction, Drug ineffective, Malaise, Pericarditis, Cardiospasm, Atrial tachycardia, Muscular weakness, Anosmia, Lip swelling, Feeling abnormal, Dry skin, Amnesia, Pain, Diarrhoea, Facial pain, Dyspnoea, Palpitations, Chest pain, Tachycardia, Abdominal discomfort, Pyrexia, Angioedema, Ventricular tachycardia, Subarachnoid haemorrhage, Headache, Vomiting, Disturbance in attention, Palmoplantar keratoderma, Migraine, Tinnitus, Peripheral swelling, Pain of skin, Tension headache, Alopecia, Memory impairment, Sleep terror, Pruritus genital, Visual impairment, Diplopia, Blindness, Vasculitis, Transient ischaemic attack, COVID-19, Heart rate increased, Back pain, Muscle twitching, Hyperhidrosis, Rash papular, Dehydration, Anxiety, Carotid artery occlusion, Nausea, Myocardial infarction, Diabetes mellitus inadequate control, Product administration error, Incorrect product administration duration, Product use in unapproved indication, Off label use, Medication error, |
||||
CANDESARTAN, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, RAMIPRIL, RAMIPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, DABIGATRAN ETEXILATE, DABIGATRAN ETEXILATE, DABIGATRAN ETEXILATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, SPIRONOLACTONE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, DEXTROSE MONOHYDRATE, DEXTROSE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, SIMVASTATIN, DAPAGLIFLOZIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LINAGLIPTIN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, NAPROXEN, NAPROXEN SODIUM, TORSEMIDE, VORTIOXETINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
577 | 25114172 |
US |
32 | 2 |
Uterine cancer, Dyspnoea, Chest discomfort, Hysterectomy, |
||||
DUPILUMAB, DUPILUMAB, |
||||
578 | 25114179 |
US |
2 | |
Influenza like illness, Pleural effusion, Dyspnoea, Nasopharyngitis, |
||||
EVOLOCUMAB, |
||||
579 | 25114203 |
US |
68 | 1 |
Cardiac disorder, Dyspnoea, |
||||
IBRUTINIB, ALLOPURINOL, SACUBITRIL AND VALSARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PROCHLORPERAZINE MALEATE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
580 | 25114226 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Pericarditis, Rheumatoid arthritis, Systemic lupus erythematosus, Gastrointestinal disorder, Arthralgia, Hepatic enzyme increased, Fatigue, Hypersensitivity, Exposure during pregnancy, Pain, Pemphigus, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, HYDROCORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-ADAZ, ABATACEPT, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOCILIZUMAB, |
||||
581 | 25114233 |
US |
26 | 1 |
Skin exfoliation, Pigmentation disorder, Dyspnoea, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
582 | 25114249 |
US |
2 | |
Swelling, Dyspnoea, Diarrhoea, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
583 | 25114286 |
US |
85 | 1 |
Cough, Dyspnoea, Incorrect dose administered, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, |
||||
584 | 25114317 |
US |
9 | 1 |
Pain, Nausea, Pyrexia, Rhinorrhoea, Dyspnoea, Anxiety, Circumstantiality, Dizziness, Eye pruritus, |
||||
DUPILUMAB, |
||||
585 | 25114335 |
2 | ||
Pulmonary arterial hypertension, Dyspnoea, Pulmonary oedema, Pneumonia, |
||||
MACITENTAN, |
||||
586 | 25114349 |
US |
62 | 2 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
587 | 25114375 |
US |
15 | 2 |
Dyspnoea, Nasopharyngitis, Injection site pain, |
||||
DUPILUMAB, |
||||
588 | 25114401 |
US |
55 | 2 |
Impaired quality of life, Asthma, Dyspnoea, Respiratory tract infection, |
||||
DUPILUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BENZONATATE, CROMOLYN SODIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FAMOTIDINE, BENRALIZUMAB, FLUCONAZOLE, FLUCONAZOLE, GABAPENTIN, GABAPENTIN, HYDRALAZINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LACTULOSE, LORAZEPAM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOCARBAMOL, METHOCARBAMOL TABLETS, MOMETASONE, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYBUTYNIN, PANTOPRAZOLE, PREDNISONE, PREDNISONE, LIRAGLUTIDE, MONTELUKAST SODIUM, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, SERTRALINE HYDROCHLORIDE, |
||||
589 | 25114415 |
US |
60 | |
Dyspnoea, Dysphagia, Myalgia, Muscle spasms, Constipation, Heart rate irregular, Sleep apnoea syndrome, Fatigue, |
||||
DURVALUMAB, MIFEPRISTONE, MIFEPRISTONE, AMLODIPINE, BISOPROLOL FUMARATE, FENOFIBRATE, HYDROCHLOROTHIAZIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, PIOGLITAZONE, TIOTROPIUM BROMIDE AND OLODATEROL, INSULIN DEGLUDEC, |
||||
590 | 25114422 |
US |
35 | 2 |
Bronchitis, Wheezing, Nasal congestion, Upper-airway cough syndrome, Dyspnoea, Fatigue, Headache, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AZELASTINE, MONTELUKAST SODIUM, |
||||
591 | 25114460 |
US |
1 | |
Dyspnoea, Hypertonic bladder, |
||||
DUPILUMAB, DUPILUMAB, |
||||
592 | 25114475 |
US |
73 | 2 |
Flushing, Dyspnoea, |
||||
NIVOLUMAB, |
||||
593 | 25114573 |
US |
75 | 2 |
Dyspnoea, Condition aggravated, Arthritis, Influenza, Oropharyngeal pain, |
||||
DUPILUMAB, |
||||
594 | 25114609 |
US |
20 | 2 |
Dyspnoea, Asthenia, Pain in extremity, Arthralgia, Periorbital swelling, Loss of personal independence in daily activities, Injection site pain, Lack of injection site rotation, |
||||
DUPILUMAB, |
||||
595 | 25114646 |
TW |
52 | 2 |
Anaphylactic shock, Dyspnoea, Tachypnoea, Hypotension, Palpitations, Headache, Abdominal discomfort, |
||||
PACLITAXEL, |
||||
596 | 25114697 |
US |
57 | 2 |
Sjogren^s syndrome, Dyspnoea, Blood pressure systolic inspiratory decreased, Pericardial effusion, |
||||
PREDNISONE, PREDNISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, COLCHICINE, |
||||
597 | 25114704 |
US |
1 | |
Dysuria, Muscle tightness, Secretion discharge, Orthostatic hypotension, Dyspnoea, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, LENVATINIB, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, GUAIFENESIN, EMPAGLIFLOZIN, LORATADINE, LORATADINE ORAL, METOPROLOL TARTRATE, METOPROLOL, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RANOLAZINE, EXTENDED-RELEASE, |
||||
598 | 25114806 |
US |
2 | |
Dyspnoea, Arthralgia, |
||||
RISANKIZUMAB-RZAA, |
||||
599 | 25114820 |
US |
67 | 2 |
Dyspnoea, Gastrooesophageal reflux disease, Dry skin, Tongue dry, Epistaxis, Oxygen saturation decreased, |
||||
LAZERTINIB, AMIVANTAMAB, |
||||
600 | 25114848 |
CN |
74 | 1 |
Laryngeal oedema, Dyspnoea, Chest discomfort, Cyanosis, Aphasia, |
||||
IOMEPROL INJECTION, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28